Literature DB >> 8638416

Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells.

S Himathongkham1, P A Luciw.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) is restricted for replication in rhesus macaque cells and does not establish infection in this species. The block to productive infection of macaque peripheral blood mononuclear cells (PBMC) in culture was investigated. A chimeric virus SHIV containing HIV-1 tat, rev, and env and all other genes from a simian immunodeficiency virus clone pathogenic in macaques (i.e., SIVmec239) replicated efficiently in macaque PBMC. Thus, the attachment step, involving interaction of the HIV-1 env glycoprotein with the cell surface CD4 receptor, is not blocked. Analysis of uptake of HIV-1 particles in these cells revealed a small reduction in virion entry; however, viral DNA synthesis, measured by PCR amplification, was greatly reduced. Taken together, these results indicate that the block to HIV-1 (subtype B) replication in rhesus macaque cells involves release of the virion core into the cytoplasm and/or a step immediately prior to initiation of reverse transcription. Further studies are required to characterize this block through identification of species-specific cellular proteins that interact with HIV-1 proteins in the early phase of viral replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8638416     DOI: 10.1006/viro.1996.0276

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  57 in total

1.  Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells.

Authors:  Theodora Hatziioannou; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.

Authors:  Neeltje A Kootstra; Carsten Munk; Nina Tonnu; Nathaniel R Landau; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

3.  Retroviral restriction factor TRIM5alpha is a trimer.

Authors:  Claudia C Mische; Hassan Javanbakht; Byeongwoon Song; Felipe Diaz-Griffero; Matthew Stremlau; Bettina Strack; Zhihai Si; Joseph Sodroski
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 4.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

5.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

6.  Cellular restriction of retrovirus particle-mediated mRNA transfer.

Authors:  Melanie Galla; Axel Schambach; Greg J Towers; Christopher Baum
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

Review 7.  Host restriction factors blocking retroviral replication.

Authors:  Daniel Wolf; Stephen P Goff
Journal:  Annu Rev Genet       Date:  2008       Impact factor: 16.830

8.  Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239.

Authors:  L Marcon; H Choe; K A Martin; M Farzan; P D Ponath; L Wu; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

9.  Hsp70 interacts with the retroviral restriction factor TRIM5alpha and assists the folding of TRIM5alpha.

Authors:  Chae Young Hwang; Jens Holl; Devi Rajan; Younglang Lee; Susan Kim; Moonkyoung Um; Ki-Sun Kwon; Byeongwoon Song
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

10.  Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.

Authors:  Theodora Hatziioannou; David Perez-Caballero; Annie Yang; Simone Cowan; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.